CIP
INSM icon

Chartwell Investment Partners’s Insmed INSM Stock Holding History

Chartwell Investment Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.1M Buy
15,069
+122
+0.8% +$9K 0.04% 350
2024
Q2 		$1M Sell
14,947
-14,469
-49% -$561K 0.04% 347
2024
Q1 		$798K Buy
29,416
+5,417
+23% +$152K 0.03% 381
2023
Q4 		$744K Buy
23,999
+10,338
+76% +$268K 0.03% 384
2023
Q3 		$345K Hold
13,661
– – 0.01% 404
2023
Q2 		$288K Buy
13,661
+664
+5% +$12.6K 0.01% 403
2023
Q1 		$221K Sell
12,997
-8,772
-40% -$170K 0.01% 406
2022
Q4 		$435K Buy
21,769
+1,240
+6% +$24K 0.02% 386
2022
Q3 		$442K Buy
+20,529
New +$492K 0.02% 391
2018
Q4 		– Sell
-34,371
Closed -$695K – 456
2018
Q3 		$695K Sell
34,371
-52,927
-61% -$1.2M 0.02% 452
2018
Q2 		$2.06M Buy
87,298
+34,670
+66% +$892K 0.06% 363
2018
Q1 		$1.19M Sell
52,628
-52,535
-50% -$1.38M 0.04% 362
2017
Q4 		$3.28M Sell
105,163
-7,062
-6% -$209K 0.11% 268
2017
Q3 		$3.5M Sell
112,225
-28,793
-20% -$548K 0.12% 243
2017
Q2 		$2.42M Buy
+141,018
New +$2.41M 0.09% 265

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chartwell Investment Partners's INSM Position: Q3 2024 in Review

Chartwell Investment Partners increased its Insmed (INSM) stake by 0.82% in Q3 2024, buying an estimated $9K and bringing the position to 15,069 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #350.

Chartwell Investment Partners first reported a position in INSM in Q2 2017 and has held it in 15 quarters since. The position peaked at $3.5M in Q3 2017. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Chartwell Investment Partners held 15,069 shares of Insmed worth $1.1M as of Q3 2024.
  • Chartwell Investment Partners bought 122 Insmed shares in Q3 2024, an estimated $9K.
  • Insmed made up 0.04% of Chartwell Investment Partners's portfolio in Q3 2024, its #350 holding.
  • Chartwell Investment Partners first reported a position in Insmed in Q2 2017 and has held it in 15 quarters since.
  • Chartwell Investment Partners's Insmed position peaked at $3.5M in Q3 2017.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.